Skip to main content
Log in

Lazaroids inhibit proliferation of cultured human astrocytoma cells

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Lazaroids (or 21-aminosteroids) are potent lipid peroxidation inhibitors and are more potent antioxidants than steroids which have been shown to suppress tumor proliferation. The effects of two lazaroid compounds (U-75389G and U-83836E) were tested on the proliferation of a human brain astrocytoma cell line U-373 MG. Both lazaroids had dose-dependent growth-inhibitory effects on the proliferation of U-373 MG. For purposes of comparison, two steroids (methylprednisolone and dexamethasone) and a highly potent antioxidant (alpha-tocopherol) were tested under similar experimental conditions and were found to have antiproliferative effects as well, although at higher dose ranges. As cell growth-inhibitors, lazaroids are more effective than alpha-tocopherol while they are advantageous over glucocorticoids for their actions are devoid of the usual glucocorticoid side-effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Braughler JM, Pregenzer JF: The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med 7:125–130,1989

    Google Scholar 

  2. Hall DH, McCall JM, Chase RL, Yonkers PA, Braughler JM: A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther 242:137–142,1987

    Google Scholar 

  3. Braughler JM, Burton PS, Chase RL, Prezenger JF, Jacobsen EJ, Vandoornik FJ, Tustin JM, Ayer DE, Bundy GL: Novel inhibitors of iron-dependent chelators as inhibitors of iron-dependent lipid peroxidation. Biochem Pharmacol 37: 3853–3860,1988

    Google Scholar 

  4. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1–14,1984

    Google Scholar 

  5. Yu BP: Cellular defenses against damage from reactive oxygen species. Physiol Rev 74:139–162,1994

    Google Scholar 

  6. Nagy K, Pasti G, Bene L, Nagy IZS: Induction of granulocytic maturation in HL-60 human leukemia cells by free radicals: a hypothesis of cell differentiation involving hydroxyl radicals. Free Radic Res Commun 19:1–15,1993

    Google Scholar 

  7. Kimura M, Maeda K, Hayashi S: Cytosolic calcium increase in coronary endothelial cells after H2O2 exposure and the inhibitory effect of U-78517F. Br J Pharmacol 107:488–493, 1992

    Google Scholar 

  8. Doan TN, Gentry DL, Taylor AA, Elliot SJ: Hydrogen peroxide activates agonist-sensitive Ca2+-flux pathways in canine venous endothelial cells. Biochem J 297:209–215,1994

    Google Scholar 

  9. Rohn TT, Hinds TR, Vincenzi FF: Ion transport ATPases as targets for free radical damage. Biochem Pharmacol 46: 525–534,1993

    Google Scholar 

  10. Taker MM, Garcia JGN, Natarajan V: Hydroperoxide-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch Biochem Biophys 303:260–266,1993

    Google Scholar 

  11. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC: Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid: role of protein kinase C. Nucl Acids Res 21:1259–1263,1993

    Google Scholar 

  12. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC: Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 8:2759–2764,1993

    Google Scholar 

  13. Nakamura Y, Gindhart TD, Winterstein D, Seed JL, Colburn NH: Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis 9:203–207,1988

    Google Scholar 

  14. Ozer NK, Palozza P, Boscoboinik D, Azzi A: d-α-Tocophe-rol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett 322:307–310,1993

    Google Scholar 

  15. Tutton PJM, Barla DH: Steroid hormones as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells. Anticancer Res 8:451–456,1988

    Google Scholar 

  16. Lee YS, Wurster RD: Dual effects of estrogen and antiestrogens on the growth of SK-N-MC human neuroblastoma cells. Cancer Lett 86:119–125,1994

    Google Scholar 

  17. Ryungsoon SK, Zabornik CLF, Begleiter A, LaBella FS: Antiproliferative properties of aminosteroid antioxidants on cultured cancer cells. Cancer Lett 64:61–66,1992

    Google Scholar 

  18. Hall ED, Yonkers PA, Horan KL, Braughler JM: Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of vitamin E by the 21-aminosteroid U-740067: evidence for an in vivo antioxidant action. J Neurotrauma 6:169–176,1989

    Google Scholar 

  19. Braughler JM, Prezenger JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262: 10438–10440,1987

    Google Scholar 

  20. Lee YS, Sayeed MM, Wurster RD: Inhibition by Ca2+ channel antagonists of the cell growth and intracellular Ca2+ mobilization in human brain tumor cells. Mol Chem Neuropathol 22:81–95,1994

    Google Scholar 

  21. Ashendel CL, Minor PL: Mechanism of phorbol ester activation of calcium-activated, phospholipid-dependent protein kinase. Carcinogenesis 7:517–521,1986

    Google Scholar 

  22. Audos KL, Guillot FL, Braughler JM: Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radic Biol Med 11: 361–371,1991

    Google Scholar 

  23. Braughler JM, Chase RL, Neff GL, Day JS, Yonkers PA, Hall ED, Sethy VH, Lahti RA: A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates ACTH se cretion and blocks arachidonic acid release from mouse pituitary (AtT-20) cells. J Pharmacol Exp Ther 244:423–427, 1988

    Google Scholar 

  24. Tarboletti G, Perin L, Botazzi B, Mantovani A, Giavazzi R, Salmona M: Membrane fluidity affects tumor-cell motility, invasion and lung- colonizing potential. Int J Cancer 44: 707–713,1989

    Google Scholar 

  25. Tomohiro Y, Obata Y, Ishikawa G, Ichikawa T: Enhancing effect of dietary iron on lung tumorigenesis. Cancer Lett 76: 57–62,1994

    Google Scholar 

  26. Singh JP, Bonin PD: Inhibition of proliferation of fibroblasts by lazaroids (21-aminosteroids). Life Sci 49:2053–2058,1991

    Google Scholar 

  27. Mattanna A, Bennardini F, Juliano C, Picci V, Marceddu S, Sciola L, Pippia P, Franconi F: Cytotoxicity of lazaroid U-754126E in human epithelial cell line (WISH). Biochem Pharmacol 48:259–265,1994

    Google Scholar 

  28. Kennedy AR, Troll W, Little B: Role of free radicals in the initiation and promotion of radiation transformation in vitro. Carcinogenesis 5:510: 1213–18

  29. Fleishaker JC, Hulst LK, Peters GR: Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5–10 days in healthy volunteers. Int J Clin Pharmacol and Therapeutics 32(5): 223–230,1994

    Google Scholar 

  30. Fleishaker JC, Peters GR, Cathhurt KS: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate. a 21-aminosteroid free radical scavenger: I. Single-dose administration. J Clin Pharmacol 33:175–181,1993

    Google Scholar 

  31. Flesishaker JC, Peters GR, Cathhurt KS, Steenwyck RC: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration. J Clin Pharmacol 33:182–190, 1993

    Google Scholar 

  32. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachinoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82(5):786–790,1995

    Google Scholar 

  33. Anonymous: Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). Stroke 25(2):418–423, 1994

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arora, P., Lee, Y.S., Origitano, T.C. et al. Lazaroids inhibit proliferation of cultured human astrocytoma cells. J Neuro-Oncol 29, 143–148 (1996). https://doi.org/10.1007/BF00182137

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182137

Key words

Navigation